307 related articles for article (PubMed ID: 11713097)
1. Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma.
Cao XX; Mohuiddin I; Ece F; McConkey DJ; Smythe WR
Am J Respir Cell Mol Biol; 2001 Nov; 25(5):562-8. PubMed ID: 11713097
[TBL] [Abstract][Full Text] [Related]
2. Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma.
Mohiuddin I; Cao X; Fang B; Nishizaki M; Smythe WR
Cancer Gene Ther; 2001 Aug; 8(8):547-54. PubMed ID: 11571532
[TBL] [Abstract][Full Text] [Related]
3. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
[TBL] [Abstract][Full Text] [Related]
5. Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product.
Smythe WR; Mohuiddin I; Ozveran M; Cao XX
J Thorac Cardiovasc Surg; 2002 Jun; 123(6):1191-8. PubMed ID: 12063468
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation.
Saltzman A; Munro R; Searfoss G; Franks C; Jaye M; Ivashchenko Y
Exp Cell Res; 1998 Jul; 242(1):244-54. PubMed ID: 9665822
[TBL] [Abstract][Full Text] [Related]
7. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
[TBL] [Abstract][Full Text] [Related]
8. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
[TBL] [Abstract][Full Text] [Related]
9. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
[TBL] [Abstract][Full Text] [Related]
10. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
Liu QY; Stein CA
Clin Cancer Res; 1997 Nov; 3(11):2039-46. PubMed ID: 9815595
[TBL] [Abstract][Full Text] [Related]
11. Activation of caspase-8 in transforming growth factor-beta-induced apoptosis of human hepatoma cells.
Shima Y; Nakao K; Nakashima T; Kawakami A; Nakata K; Hamasaki K; Kato Y; Eguchi K; Ishii N
Hepatology; 1999 Nov; 30(5):1215-22. PubMed ID: 10534343
[TBL] [Abstract][Full Text] [Related]
12. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL.
Rashmi R; Kumar S; Karunagaran D
Carcinogenesis; 2005 Apr; 26(4):713-23. PubMed ID: 15661804
[TBL] [Abstract][Full Text] [Related]
13. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral transfer of mda-7 leads to BAX up-regulation and apoptosis in mesothelioma cells, and is abrogated by over-expression of BCL-XL.
Cao XX; Mohuiddin I; Chada S; Mhashilkar AM; Ozvaran MK; McConkey DJ; Miller SD; Daniel JC; Smythe WR
Mol Med; 2002 Dec; 8(12):869-76. PubMed ID: 12606823
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta induces cell death in the oligodendroglial cell line OLI-neu.
Schuster N; Bender H; Philippi A; Subramaniam S; Strelau J; Wang Z; Krieglstein K
Glia; 2002 Oct; 40(1):95-108. PubMed ID: 12237847
[TBL] [Abstract][Full Text] [Related]
17. Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells.
Kondo S; Shinomura Y; Kanayama S; Higashimoto Y; Kiyohara T; Zushi S; Kitamura S; Ueyama H; Matsuzawa Y
Oncogene; 1998 Nov; 17(20):2585-91. PubMed ID: 9840921
[TBL] [Abstract][Full Text] [Related]
18. Activation and relocalization of caspase 3 during the apoptotic cascade of human mesothelioma cells.
Soini Y; Kahlos K; Sormunen R; Säily M; Mäntymaa P; Koistinen P; Pääkkö P; Kinnula V
APMIS; 2005 Jun; 113(6):426-35. PubMed ID: 15996160
[TBL] [Abstract][Full Text] [Related]
19. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax.
Aggarwal S; Gupta S
J Immunol; 1998 Feb; 160(4):1627-37. PubMed ID: 9469419
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B
Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
